Stocks and Investing
Stocks and Investing
Fri, June 26, 2020
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
Thu, June 25, 2020
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
Martin Auster Maintained (UTHR) at Buy with Increased Target to $145 on, Jun 25th, 2020
Martin Auster of Credit Suisse, Maintained "United Therapeutics Corporation" (UTHR) at Buy with Increased Target from $129 to $145 on, Jun 25th, 2020.
Martin has made no other calls on UTHR in the last 4 months.
There is 1 other peer that has a rating on UTHR. Out of the 1 peers that are also analyzing UTHR, 0 agree with Martin's Rating of Hold.
This is the rating of the analyst that currently disagrees with Martin
- Eun Yang of "Jefferies" Upgraded from Hold to Strong Buy and Increased Target to $123 on, Tuesday, March 10th, 2020